Form 4: Centene COO Susan Smith Awarded Equity

Centene's Chief Operating Officer, Susan Raye Smith, received an equity award of 112,823 shares of common stock, comprising restricted and performance stock units.

Summary

• Susan Raye Smith, Chief Operating Officer of Centene Corp (CNC), was granted an award of 112,823 shares of common stock on January 26, 2026.
• The award consists of 45,129 restricted stock units (RSUs) and 67,694 performance stock units (PSUs) reported at target level performance.
• The RSUs will vest in three annual installments, commencing on March 15, 2027.
• The PSUs are scheduled to vest on March 15, 2029, with the actual number ranging from 0% to 200% of the target based on the Company's stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028.
• Following this transaction, Susan Raye Smith beneficially owns 225,289 shares, which includes 90,117 shares of previously-granted RSUs and PSUs still subject to vesting requirements.

Sentiment

Score: 6

Explanation: The filing reports a routine executive equity award, which is generally a neutral to slightly positive event as it aligns management incentives with shareholder interests. It does not contain information that would significantly alter the company's immediate outlook.

Positives

• The equity award aligns the Chief Operating Officer's interests with those of shareholders, as a significant portion of her compensation is tied to the company's future stock performance.
• The inclusion of performance stock units (PSUs) incentivizes long-term value creation and strategic execution, directly linking executive compensation to company performance metrics.

Risks

• The actual number of performance stock units that will vest can range from 0% to 200% of the reported target, introducing variability in the executive's compensation based on future stock price performance.

Future Outlook

The future compensation for the Chief Operating Officer is partially tied to the company's stock price performance, with performance stock units vesting based on a comparison of stock prices between late 2025 and late 2028.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity transaction, common in publicly traded companies as part of executive compensation packages. It reflects the company's strategy to incentivize its leadership through long-term equity awards, a standard practice across various industries, including healthcare.

Comparison to Industry Standards

• The use of both Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) is a common practice in executive compensation across the S&P 500, aligning with best practices for linking pay to performance and retention.
• The vesting schedule for RSUs (three annual installments) is typical for executive retention, similar to programs at peer healthcare companies like UnitedHealth Group or Anthem (now Elevance Health).
• The performance criteria for PSUs, based on stock price performance over a multi-year period, is a standard approach to incentivize long-term shareholder value creation, comparable to structures seen in other large-cap companies.

Corporate Governance

Related Party Transactions

• The transaction involves an equity award to a Chief Operating Officer, which is a standard form of compensation for an insider and is disclosed as a related party transaction under SEC rules.

Stakeholder Impact

• Shareholders: The equity award structure, particularly the performance stock units, aims to align the Chief Operating Officer's financial interests with long-term shareholder value, potentially leading to improved company performance.
• Employees: While not directly impacting all employees, executive compensation practices can influence overall company culture and compensation philosophy.

Next Steps

• The 45,129 restricted stock units will begin vesting in three annual installments starting March 15, 2027.
• The 67,694 performance stock units will vest on March 15, 2029, contingent on the company's stock price performance.

Key Dates

Keywords

Centene Corp, CNC, Susan Raye Smith, Chief Operating Officer, SEC Form 4, Insider Transaction, Equity Award, Restricted Stock Units, Performance Stock Units, Executive Compensation